STENTiT implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in the VITAL-IT 1 study evaluating the ...

Foldax today announced one-year results from a clinical trial of its Tria polymer mitral heart valve offering.

Circa Scientific announced that it completed the limited market release for its CrossWise RF transseptal access system.

Bausch + Lomb (NYSE:BLCO) announced that its subsidiaries closed an upsized offering of $790.6 million (€675 million) in ...

Danaher (NYSE:DHR) announced today that it appointed a new chief technology and AI officer and a new EVP to lead Life Sciences.